V. Behrana Jensen

6.7k total citations
23 papers, 876 citations indexed

About

V. Behrana Jensen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, V. Behrana Jensen has authored 23 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in V. Behrana Jensen's work include Bacterial biofilms and quorum sensing (6 papers), Ion Transport and Channel Regulation (4 papers) and Bacterial Genetics and Biotechnology (4 papers). V. Behrana Jensen is often cited by papers focused on Bacterial biofilms and quorum sensing (6 papers), Ion Transport and Channel Regulation (4 papers) and Bacterial Genetics and Biotechnology (4 papers). V. Behrana Jensen collaborates with scholars based in United States, Germany and Denmark. V. Behrana Jensen's co-authors include Susanne Häußler, Denitsa Eckweiler, Andreas Dötsch, Robert Geffers, Maren Scharfe, Monika Schniederjans, Oleh Pochynyuk, Mykola Mamenko, Guido Dieterich and Florian Bredenbruch and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemistry.

In The Last Decade

V. Behrana Jensen

21 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Behrana Jensen United States 14 566 201 141 114 98 23 876
Leslie L. Waite United States 14 559 1.0× 218 1.1× 110 0.8× 112 1.0× 28 0.3× 16 975
Qinghua Hu China 17 318 0.6× 61 0.3× 207 1.5× 247 2.2× 55 0.6× 41 906
Roald Ravatn United States 13 508 0.9× 197 1.0× 72 0.5× 49 0.4× 110 1.1× 15 838
Takeshi Masaki Japan 8 270 0.5× 132 0.7× 107 0.8× 79 0.7× 30 0.3× 17 642
Félix Claverie-Martı́n Spain 28 1.3k 2.3× 641 3.2× 47 0.3× 36 0.3× 46 0.5× 79 2.0k
Jaleh Malakooti United States 20 665 1.2× 244 1.2× 14 0.1× 63 0.6× 65 0.7× 33 927
Gun‐Hwa Kim South Korea 18 599 1.1× 70 0.3× 55 0.4× 32 0.3× 40 0.4× 54 1.0k
Corinne E. Gustafson United States 18 773 1.4× 99 0.5× 23 0.2× 70 0.6× 154 1.6× 27 1.2k
Sumantra Chatterjee United States 19 635 1.1× 213 1.1× 62 0.4× 220 1.9× 142 1.4× 58 1.3k
Yuichi Someya Japan 15 328 0.6× 253 1.3× 146 1.0× 22 0.2× 182 1.9× 42 944

Countries citing papers authored by V. Behrana Jensen

Since Specialization
Citations

This map shows the geographic impact of V. Behrana Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Behrana Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Behrana Jensen more than expected).

Fields of papers citing papers by V. Behrana Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Behrana Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Behrana Jensen. The network helps show where V. Behrana Jensen may publish in the future.

Co-authorship network of co-authors of V. Behrana Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of V. Behrana Jensen. A scholar is included among the top collaborators of V. Behrana Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Behrana Jensen. V. Behrana Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DiPeri, Timothy P., Kurt W. Evans, Ming Zhao, et al.. (2024). Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts. Cancer Discovery. 14(5). 828–845. 20 indexed citations
2.
Devarajan, Eswaran, Hannah C. Beird, Wei‐Lien Wang, et al.. (2024). Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases. Discover Oncology. 15(1). 232–232.
3.
Jensen, V. Behrana, et al.. (2022). Pathology in Practice. Journal of the American Veterinary Medical Association. 259(S2). 1–4.
4.
Kundra, Vikas, Murali K. Ravoori, John Stewart, et al.. (2020). Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma. International Journal of Cancer. 148(8). 1928–1937. 11 indexed citations
5.
Yan, Xiang, Xiaoshan Zhang, Li Wang, et al.. (2018). Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis. Cancer Research. 79(1). 125–132. 62 indexed citations
6.
Mamenko, Mykola, Oleg Zaika, Viktor Tomilin, V. Behrana Jensen, & Oleh Pochynyuk. (2018). Compromised regulation of the collecting duct ENaC activity in mice lacking AT 1a receptor. Journal of Cellular Physiology. 233(9). 7217–7225. 11 indexed citations
7.
Mamenko, Mykola, Nabila Boukelmoune, Viktor Tomilin, et al.. (2017). The renal TRPV4 channel is essential for adaptation to increased dietary potassium. Kidney International. 91(6). 1398–1409. 40 indexed citations
8.
Eckweiler, Denitsa, V. Behrana Jensen, Boyke Bunk, et al.. (2017). Identification of a Pseudomonas aeruginosa PAO1 DNA Methyltransferase, Its Targets, and Physiological Roles. mBio. 8(1). 35 indexed citations
9.
Prieto, Minolfa C., Virginia Reverte, Mykola Mamenko, et al.. (2017). Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice. American Journal of Physiology-Renal Physiology. 313(6). F1243–F1253. 53 indexed citations
10.
Jensen, V. Behrana, et al.. (2016). Effects of Environmental Enrichment on the Fertility and Fecundity of Zebrafish (Danio rerio).. PubMed. 55(3). 291–4. 27 indexed citations
11.
Bielecki, Piotr, V. Behrana Jensen, Wiebke Manuela Schulze, et al.. (2015). Cross talk between the response regulators PhoB and TctD allows for the integration of diverse environmental signals inPseudomonas aeruginosa. Nucleic Acids Research. 43(13). 6413–6425. 45 indexed citations
12.
Jensen, V. Behrana, Steven R. Talbot, Winfried Hofmann, et al.. (2015). Comprehensive MALDI-TOF Biotyping of the Non-Redundant Harvard Pseudomonas aeruginosa PA14 Transposon Insertion Mutant Library. PLoS ONE. 10(2). e0117144–e0117144. 8 indexed citations
13.
Mamenko, Mykola, Oleg Zaika, Minolfa C. Prieto, et al.. (2013). Chronic Angiotensin II Infusion Drives Extensive Aldosterone-Independent Epithelial Na + Channel Activation. Hypertension. 62(6). 1111–1122. 57 indexed citations
14.
Dötsch, Andreas, Denitsa Eckweiler, Monika Schniederjans, et al.. (2012). The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing. PLoS ONE. 7(2). e31092–e31092. 190 indexed citations
15.
Jensen, V. Behrana, et al.. (2010). Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report. Journal of Medical Case Reports. 4(1). 131–131. 8 indexed citations
16.
Jensen, V. Behrana, Anil Prasad, Aaron P. Smith, et al.. (2009). Prognostic Criteria for Squamous Cell Cancer of the Skin. Journal of Surgical Research. 159(1). 509–516. 25 indexed citations
17.
Jensen, V. Behrana, et al.. (2009). The Pho regulon influences biofilm formation and type three secretion in Pseudomonas aeruginosa. Environmental Microbiology Reports. 1(6). 488–494. 26 indexed citations
18.
Jensen, V. Behrana, et al.. (2006). RhlR Expression inPseudomonas aeruginosaIs Modulated by thePseudomonasQuinolone Signal via PhoB-Dependent and -Independent Pathways. Journal of Bacteriology. 188(24). 8601–8606. 128 indexed citations
19.
Kiær, Henrik, et al.. (1997). Prognostic comparison of three classifications for medullary carcinomas of the breast. Histopathology. 30(6). 523–532. 53 indexed citations
20.
Jensen, V. Behrana, Marianne Lidang Jensen, Henrik Kiær, Jørn Andersen, & F. Melsen. (1997). MIB-1 Expression in breast carcinomas with medullary features. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 431(2). 125–130. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie L. Waite Breakdown of academic impact, for papers by Qinghua Hu Breakdown of academic impact, for papers by Roald Ravatn Breakdown of academic impact, for papers by Takeshi Masaki Breakdown of academic impact, for papers by Félix Claverie-Martı́n Breakdown of academic impact, for papers by Jaleh Malakooti Breakdown of academic impact, for papers by Gun‐Hwa Kim Breakdown of academic impact, for papers by Corinne E. Gustafson Breakdown of academic impact, for papers by Sumantra Chatterjee Breakdown of academic impact, for papers by Yuichi Someya
Rankless by CCL
2026